| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/06/2008 | CN100366289C Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 02/06/2008 | CN100366288C Dental ulcerative glue |
| 02/06/2008 | CN100366287C Composition for the prevention and treatment of cellulitis |
| 02/06/2008 | CN100366286C Saposin C-DOPS: a novel anti-tumor agent |
| 02/06/2008 | CN100366255C Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 02/06/2008 | CN100366254C Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 02/06/2008 | CN100366248C Skin care composition for mediating cell to cell communication |
| 02/05/2008 | US7326778 Mutator gene and hereditary non-polyposis colorectal cancer |
| 02/05/2008 | US7326775 purification of transferrins using surfactants, antioxidants and flavonoids, than drying the pure glycoproteins |
| 02/05/2008 | US7326769 Subjecting an extract of a group 1, 2, 3, 10, and/or 13 Phleum pretense to hydrophobic interaction chromatography, followed by gel filtration and optionally followed by cation exchanger chromatography; facilitate improved diagnosis of pollen allergies |
| 02/05/2008 | US7326768 Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 02/05/2008 | US7326767 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326693 Antisense modulation of c-reactive protein expression |
| 02/05/2008 | US7326692 Induction of immunity using inhibitors of granzymes |
| 02/05/2008 | US7326690 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 02/05/2008 | US7326689 Pseudomycins useful against plant diseases |
| 02/05/2008 | US7326688 Analogs of gastric inhibitory polypeptide and their use of treatment for diabetes |
| 02/05/2008 | US7326687 CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 02/05/2008 | US7326686 Compounds and methods for regulating cell adhesion |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | US7326684 Peptides for enhancing resistance to microbial infections |
| 02/05/2008 | US7326683 Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
| 02/05/2008 | US7326682 Conotoxin peptides |
| 02/05/2008 | US7326681 Methods for producing modified glycoproteins |
| 02/05/2008 | US7326680 Administering adrenomedullin for inhibiting abnormal bradykinin-induced myometrial contraction |
| 02/05/2008 | US7326679 Anticancer peptide compositions |
| 02/05/2008 | US7326678 Obesity-related disease or disorder, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 02/05/2008 | US7326571 Decellularized bone marrow extracellular matrix |
| 02/05/2008 | US7326570 Induction of tubular morphogenesis using pleiotrophin |
| 02/05/2008 | US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2008 | US7326542 Compositions and methods for regulating bacterial pathogenesis |
| 02/05/2008 | US7326541 Fragments and variants of Staphylococcus aureus DNAG primase, and uses thereof |
| 02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
| 02/05/2008 | US7326536 Agents for treatment of HCV and methods of use |
| 02/05/2008 | US7326535 Using a for diagnosis, therapy |
| 02/05/2008 | US7326529 Using cancer specific genes |
| 02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
| 02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/05/2008 | US7326413 Antibodies against the PRO1434 polypeptide |
| 02/05/2008 | US7326412 Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation |
| 02/05/2008 | US7326411 Use of amino-terminally truncated RANTES to inhibit HIV viral replication |
| 02/05/2008 | US7326245 Medical device for delivering biologically active material |
| 02/05/2008 | CA2315703C Tripeptidyl peptidase inhibitors |
| 02/05/2008 | CA2278140C Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| 02/05/2008 | CA2225963C Transforming growth factor beta crystals |
| 02/05/2008 | CA2218161C Peptide compositions with growth factor-like activity |
| 02/05/2008 | CA2187161C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase ii (icerel-ii) |
| 02/05/2008 | CA2166155C Agents binding to hyaluronic acid binding domains and the use thereof |
| 02/05/2008 | CA2165039C Cyclohexapeptides and their mixtures, a process for preparing them, and their use |
| 02/05/2008 | CA2156255C Soluble thrombomodulin-containing composition |
| 02/05/2008 | CA2136339C Derivatives of dolastatin |
| 02/05/2008 | CA2124953C Peptides related to prion proteins |
| 02/01/2008 | WO2007012188A1 GLP/1/EXENDM 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 02/01/2008 | CA2658673A1 Composition and method for prevention and treatment of type i and type ii diabetes |
| 01/31/2008 | WO2008014478A2 Nanocell drug delivery system |
| 01/31/2008 | WO2008014414A2 Methods for attenuating release of inflammatory mediators and peptides useful therein |
| 01/31/2008 | WO2008014252A2 Iap inhibitors |
| 01/31/2008 | WO2008014220A2 Vaccine immunotherapy |
| 01/31/2008 | WO2008014200A2 Cyclosporin compositions |
| 01/31/2008 | WO2008014054A2 Bmp-7 variant compositions, methods and uses |
| 01/31/2008 | WO2008013989A2 Methods and compositions for identifying a cellular immune response against prostate cancer |
| 01/31/2008 | WO2008013962A2 Method and mixture for in-vivo photochemical cross-linking of collagen |
| 01/31/2008 | WO2008013955A2 Sustained release formulations for pulmonary delivery |
| 01/31/2008 | WO2008013938A2 Aerosolizable formulation comprising insulin for pulmonary delivery |
| 01/31/2008 | WO2008013900A2 Osteogenic enhancer composition |
| 01/31/2008 | WO2008013633A2 Treating sex steroid responsive disorders |
| 01/31/2008 | WO2008013362A1 Anti stomach ulcer or stomach ulcer drug composition |
| 01/31/2008 | WO2008013324A1 Use of diabetes-related, liver-derived secreted protein in diagnosis or treatment of type-2 diabetes or vascular disorder |
| 01/31/2008 | WO2008013242A1 Method for production of n36-binding peptide |
| 01/31/2008 | WO2008013082A1 Galectin 9-polymer conjugate |
| 01/31/2008 | WO2008012932A1 Insulin resistance reducer |
| 01/31/2008 | WO2008012828A2 Composite implants for promoting bone regeneration and augmentation and methods for their preparation and use |
| 01/31/2008 | WO2008012796A2 Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation |
| 01/31/2008 | WO2008012629A2 Exendin fusion proteins |
| 01/31/2008 | WO2008012546A2 Azapeptides for use in therapy against interstitial cystitis |
| 01/31/2008 | WO2008012528A1 N-terminal polysialylation |
| 01/31/2008 | WO2008012503A1 Homologue of pro4426 |
| 01/31/2008 | WO2008012476A2 Use of carboxypeptidases in the cosmetics and therapeutic field |
| 01/31/2008 | WO2008012310A1 Caspofungin formulations |
| 01/31/2008 | WO2008012089A2 Polyphenol/peptide composition and use thereof for promoting gastric health |
| 01/31/2008 | WO2008012049A1 Post-translationally modified neurotrophins |
| 01/31/2008 | WO2008012019A2 Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides |
| 01/31/2008 | WO2008011752A2 Drugs for resisting bacteria, viruses, cancers, tumors, irritabilities and defects |
| 01/31/2008 | WO2008011713A1 Methods of diagnosis and treatment for metabolic disorders |
| 01/31/2008 | WO2008011709A1 Biomarkers for use in the diagnosis and treatment of colorectal cancer |
| 01/31/2008 | WO2008011672A1 A cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide |
| 01/31/2008 | WO2007143099A3 Methods for inhibiting cardiac pai-1 |
| 01/31/2008 | WO2007136295A3 Peptide substance revealing a stress protective effect, pharmaceutical composition on its base and the method of its application |
| 01/31/2008 | WO2007126392A8 Antimicrobial peptides |
| 01/31/2008 | WO2007123402A3 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene |
| 01/31/2008 | WO2007103425A3 Kits and methods for preparing pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) |
| 01/31/2008 | WO2007096855A3 Angiotensin-i-converting enzyme inhibitory |
| 01/31/2008 | WO2007094669A3 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
| 01/31/2008 | WO2007070450A3 Fast-acting oral peptide pharmaceutical products |
| 01/31/2008 | WO2007064821A3 Purified fabh polypeptides involved in bacterial fatty acid synthesis |
| 01/31/2008 | WO2007056511A3 Metal-binding therapeutic peptides |
| 01/31/2008 | WO2006134195A8 Use of a cytokine from the interleukin-6 family in the preparation of a composition for combined administration with interferon-alpha |
| 01/31/2008 | WO2006134190A8 Agents and methods based on the use of the eda domain of fibronectin |
| 01/31/2008 | WO2006092722A8 Peptidomimetic compounds and preparation of biologically active derivatives |